Infosys shares jump 4% as IT firm expects ₹1,745 crore tax refund; here’s what you need to know

Infosys, in a regulatory filing on March 31, said the orders were received on March 26 and March 27, 2026, for Assessment Years 2018–19 and 2017–18, respectively, and on March 31, 2026, for Assessment Years 2013–14, 2019–20, 2020–21, and 2021–22.

“As per the said orders, the Company expects a cumulative refund of ₹1,745 crore (including interest). The Company is currently evaluating the impact of these orders on its financial statements for the quarter and year ended March 31, 2026,” Infosys further added.

Last month, on March 26, Infosys had announced plans to acquire healthcare digital transformation company Optimum Healthcare IT and insurance consulting technology company Stratus for a cumulative amount of about ₹5,260 crore.

Infosys will acquire Optimum Healthcare IT for up to $465 million, including upfront and earnouts, excluding management incentives and retention bonuses. The buyout is expected to close during the first quarter of fiscal 2027, subject to completion of closing conditions.

Infosys share price

At 10:35 AM, Infosys shares were trading at ₹1,296.70 apiece on the National Stock Exchange, gaining 3.69%.

In the last six months, the stock has tumbled 10%. On a year-on-year basis, Infosys shares have fallen 15%.

The stock had touched its 52-week high of ₹1,728 on February 3, 2026, while its one-year low of ₹1,215.1 was hit on March 19, 2025.

The company’s market capitalisation stands at ₹5.25 lakh crore.

Infosys Q3 earnings

The country's second-largest information technology (IT) services company had reported a net profit of ₹6,654 crore in the third quarter of the current financial year (Q3FY26), marking a decline of 2.2% from ₹6,806 crore in the same period last year. On a sequential basis, Infosys net profit declined 9.6% from ₹7,364 crore in the previous quarter.

The Bengaluru-based company's revenue from operations jumped 9% annually to ₹45,479 crore from ₹41,764 crore in the year-ago period. Sequentially its revenue rose 2.2% from ₹44,490 crore. In constant currency terms, revenue rose 1.7% annually and 0.6% sequentially.

The company has raised its revenue growth guidance to 3%-3.5% from its earlier growth guidance of 2%-3%, and it expects margins to be in the range of 20%-22% for the current financial year.

At the end of the third quarter, total contract value (TCV) of large deal wins was $4.8 billion with a net new of 57%, and its headcount increased by 5,043. The company’s attrition came down to 12.3% from 14.3% in the previous quarter and 13.75% in the same period last year.